Functional Constipation (FC)
4
Pipeline Programs
2
Companies
1
Clinical Trials
2
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
2
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Peptide
2100%
On Market (2)
Approved therapies currently available
U
LINACLOTIDEApproved
linaclotide
Unknown Companyoral2023
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
AbbVieLinaclotide
Clinical Trials (1)
Total enrollment: 123 patients across 1 trials
A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation
Start: Dec 2022Est. completion: Sep 2025123 patients
Phase 3Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space